Betamethasone News

FDA Approves Taclonex (Calcipotriene/Betamethasone Dipropionate), Once Daily Therapy for Treatment of Psoriasis

Rockaway, NJ -- Warner Chilcott and LEO Pharma announced today that the United States Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Taclonex(R).